Abstract
α-Synuclein (αSN) in human is tightly linked both neuropathologically and genetically to Parkinson's disease (PD) and related disorders. Disease-causing properties in vivo of the wildtype mouse ortholog (mαSN), which carries a threonine at position 53 like the A53T human mutant version that is genetically linked to PD, were never reported. To this end we generated mouse lines that express mαSN in central neurons at levels reaching up to six-fold compared to endogenous mαSN. Unlike transgenic mice expressing human wildtype or mutant forms of αSN, these mαSN transgenic mice showed pronounced ubiquitin immunopathology in spinal cord and brainstem. Isoelectric separation of mαSN species revealed multiple isoforms including two Ser129-phosphorylated species in the most severely affected brain regions. Neuronal Ser129-phosphorylated αSN occurred in granular and small fibrillar aggregates and pathological staining patterns in neurites occasionally revealed a striking ladder of small alternating segments staining either for Ser129-phosphorylated αSN or ubiquitin but not both. Axonal degeneration in long white matter tracts of the spinal cord, with breakdown of myelin sheaths and degeneration of neuromuscular junctions with loss of integrity of the presynaptic neurofilament network in mαSN transgenic mice, was similar to what we have reported for mice expressing human αSN wildtype or mutant forms. In hippocampal neurons, the mαSN protein accumulated and was phosphorylated but these neurons showed no ubiquitin immunopathology. In contrast to the early-onset motor abnormalities and muscle weakness observed in mice expressing human αSN, mαSN transgenic mice displayed only end-stage phenotypic alterations that manifested alongside with neuropathology. Altogether these findings show that increased levels of wildtype mαSN does not induce early-onset behavior changes, but drives end-stage pathophysiological changes in murine neurons that are strikingly similar to those evoked by expression of human wildtype or mutant forms.
MeSH Terms
Animals
Axons/metabolism,pathology,ultrastructure
Blotting, Western
Brain/metabolism,pathology,physiopathology
Female
Gene Expression
Hippocampus/metabolism,pathology,physiopathology
Humans
Immunohistochemistry
In Situ Hybridization
Male
Maze Learning/physiology
Mice
Mice, Inbred C57BL
Mice, Knockout
Mice, Transgenic
Microscopy, Immunoelectron
Motor Activity/physiology
Nervous System Diseases/genetics,metabolism,physiopathology
Neuromuscular Junction/metabolism,pathology,physiopathology
Neurons/metabolism,pathology,ultrastructure
Phosphorylation
Spinal Cord/metabolism,pathology,physiopathology
Ubiquitin/metabolism
alpha-Synuclein/genetics,metabolism
Chemicals
Ubiquitin
alpha-Synuclein
Authors & Affiliations
13 authors, click to expand affiliations / ORCID
Rieker Claus
Novartis Institutes for BioMedical Research, Novartis Pharma AG, Basel, Switzerland.
Dev Kumlesh K
Lehnhoff Katja
Barbieri Samuel
Ksiazek Iwona
Kauffmann Sabine
Danner Simone
Schell Heinrich
Boden Cindy
Ruegg Markus A
Kahle Philipp J
van der Putten Herman
Shimshek Derya R
References (33)
33 references, click to expand
-
Neuropathology in mice expressing human alpha-synuclein.
J Neurosci. 2000 Aug 15;20(16):6021-9
PMID: 10934251
-
Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.
Science. 2000 Feb 18;287(5456):1265-9
PMID: 10678833
-
Subcellular localization of wild-type and Parkinson's disease-associated mutant alpha -synuclein in human and transgenic mouse brain.
J Neurosci. 2000 Sep 1;20(17):6365-73
PMID: 10964942
-
Parkinson-like neurodegeneration induced by targeted overexpression of alpha-synuclein in the nigrostriatal system.
J Neurosci. 2002 Apr 1;22(7):2780-91
PMID: 11923443
-
Abnormal distribution of the non-Abeta component of Alzheimer's disease amyloid precursor/alpha-synuclein in Lewy body disease as revealed by proteinase K and formic acid pretreatment.
Lab Invest. 1998 Sep;78(9):1169-77
PMID: 9759660
-
Subcellular localization of alpha-synuclein in primary neuronal cultures: effect of missense mutations.
J Neural Transm Suppl. 2000;(58):53-63
PMID: 11128613
-
Genetic animal models of Parkinson's disease.
Neuron. 2010 Jun 10;66(5):646-61
PMID: 20547124
-
NACP, a protein implicated in Alzheimer's disease and learning, is natively unfolded.
Biochemistry. 1996 Oct 29;35(43):13709-15
PMID: 8901511
-
The role of ubiquitin linkages on alpha-synuclein induced-toxicity in a Drosophila model of Parkinson's disease.
J Neurochem. 2009 Jul;110(1):208-19
PMID: 19457126
-
Misfolded proteinase K-resistant hyperphosphorylated alpha-synuclein in aged transgenic mice with locomotor deterioration and in human alpha-synucleinopathies.
J Clin Invest. 2002 Nov;110(10):1429-39
PMID: 12438441
-
alpha-Synuclein is phosphorylated in synucleinopathy lesions.
Nat Cell Biol. 2002 Feb;4(2):160-4
PMID: 11813001
-
Endogenous serine protease inhibitor modulates epileptic activity and hippocampal long-term potentiation.
J Neurosci. 1997 Jun 15;17(12):4688-99
PMID: 9169529
-
Part I: parkin-associated proteins and Parkinson's disease.
Neuropharmacology. 2003 Jul;45(1):1-13
PMID: 12814656
-
Hyperphosphorylation and insolubility of alpha-synuclein in transgenic mouse oligodendrocytes.
EMBO Rep. 2002 Jun;3(6):583-8
PMID: 12034752
-
Interaction of human alpha-Synuclein and Parkinson's disease variants with phospholipids. Structural analysis using site-directed mutagenesis.
J Biol Chem. 2000 Nov 3;275(44):34393-8
PMID: 10952980
-
Improvement of the solubilization of proteins in two-dimensional electrophoresis with immobilized pH gradients.
Electrophoresis. 1997 Mar-Apr;18(3-4):307-16
PMID: 9150907
-
Part II: alpha-synuclein and its molecular pathophysiological role in neurodegenerative disease.
Neuropharmacology. 2003 Jul;45(1):14-44
PMID: 12814657
-
An immunoblotting method for high-resolution isoelectric focusing of protein isoforms on immobilized pH gradients.
Electrophoresis. 2001 Jun;22(10):1887-93
PMID: 11465484
-
Dopaminergic cell loss induced by human A30P alpha-synuclein gene transfer to the rat substantia nigra.
Hum Gene Ther. 2002 Mar 20;13(5):605-12
PMID: 11916484
-
Selective insolubility of alpha-synuclein in human Lewy body diseases is recapitulated in a transgenic mouse model.
Am J Pathol. 2001 Dec;159(6):2215-25
PMID: 11733371
-
Neurofibrillary tangles in the dentate granule cells of patients with Alzheimer's disease, Lewy body disease and progressive supranuclear palsy.
Acta Neuropathol. 1997 Jan;93(1):7-12
PMID: 9006651
-
Concurrence of alpha-synuclein and tau brain pathology in the Contursi kindred.
Acta Neuropathol. 2002 Jul;104(1):7-11
PMID: 12070658
-
Alpha-synuclein in Lewy bodies.
Nature. 1997 Aug 28;388(6645):839-40
PMID: 9278044
-
Ubiquitination of alpha-synuclein is not required for formation of pathological inclusions in alpha-synucleinopathies.
Am J Pathol. 2003 Jul;163(1):91-100
PMID: 12819014
-
Clinical and neuropathological correlates of dementia with Lewy bodies.
Ann N Y Acad Sci. 2000;920:9-15
PMID: 11193181
-
Neuropathology of Parkinson's disease.
J Neuropathol Exp Neurol. 1996 Mar;55(3):259-72
PMID: 8786384
-
Molecular and clinical prodrome of Parkinson disease: implications for treatment.
Nat Rev Neurol. 2010 Jun;6(6):309-17
PMID: 20479780
-
Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.
Neuron. 2002 May 16;34(4):521-33
PMID: 12062037
-
[Neuroanatomy of Parkinson disease. Changes in the neuronal cytoskeleton of a few disease-susceptible types of neurons lead to progressive destruction of circumscribed areas in the limbic and motor systems].
Nervenarzt. 2000 Jun;71(6):459-69
PMID: 10919140
-
Establishment of a first-order kinetic model of light chain-associated amyloid fibril extension in vitro.
Biochim Biophys Acta. 2002 Nov 19;1601(1):110-20
PMID: 12429509
-
alpha-Synuclein immunoreactivity in dementia with Lewy bodies: morphological staging and comparison with ubiquitin immunostaining.
Acta Neuropathol. 2000 Apr;99(4):352-7
PMID: 10787032
-
Pattern of brain destruction in Parkinson's and Alzheimer's diseases.
J Neural Transm (Vienna). 1996;103(4):455-90
PMID: 9617789
-
Phosphorylated alpha-synuclein is ubiquitinated in alpha-synucleinopathy lesions.
J Biol Chem. 2002 Dec 13;277(50):49071-6
PMID: 12377775